Peripheral T-cell lymphoma, NEC, unspecified site is a type of non-Hodgkin lymphoma characterized by the proliferation of peripheral T-cells. This malignancy can arise from various causes, including genetic mutations and environmental factors. Accurate coding with ICD-10 Code C84.40 is essential for precise diagnosis, effective documentation, appropriate medical billing, and comprehensive public health reporting.
ICD-10 Code C84.40 represents Peripheral T-cell lymphoma, NEC, unspecified site, a hematological malignancy involving atypical T-cells. This code is utilized when the specific subtype of peripheral T-cell lymphoma is not specified, aiding in the documentation and billing processes. It is crucial for healthcare providers to use this code accurately to reflect the patient's condition and ensure appropriate reimbursement.
Peripheral T-cell lymphoma, NEC, unspecified site is a heterogeneous group of aggressive lymphomas that arise from mature T-cells. The exact etiology remains unclear, but it is associated with immune dysregulation and environmental exposures. Prompt diagnosis and treatment are critical due to the aggressive nature of the disease.
ICD-10 Code C84.40 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.
In SOAP notes, ICD-10 Code C84.40 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Peripheral T-cell lymphoma, NEC, unspecified site. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Peripheral T-cell lymphoma, NEC, unspecified site requires urgent medical intervention, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.40 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 36415 | Collection of venous blood by venipuncture. |
| 77014 | Radiologic guidance for needle placement. |
Common Questions About Using ICD-10 Code C84.40 for Peripheral T-cell lymphoma, NEC, unspecified site
What are the common symptoms of Peripheral T-cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and itching.
How is Peripheral T-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of atypical T-cells.
What treatment options are available for Peripheral T-cell lymphoma?
Treatment often includes chemotherapy, radiation therapy, and in some cases, stem cell transplantation. Supportive care is also essential to manage symptoms.
Is Peripheral T-cell lymphoma curable?
The prognosis varies based on the specific subtype and stage at diagnosis. Some patients may achieve remission, while others may have a more aggressive course.
Clinical Notes
SOAP notes
DAP notes
AI medical notes